Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001958659 | SCV002236753 | likely benign | Hypercholesterolemia, autosomal dominant, 3 | 2024-05-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002370608 | SCV002667010 | likely benign | Cardiovascular phenotype | 2021-02-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004711737 | SCV005257978 | likely benign | not provided | criteria provided, single submitter | not provided | ||
GENin |
RCV004820225 | SCV005441498 | likely benign | Familial hypercholesterolemia | 2023-08-24 | criteria provided, single submitter | clinical testing | This is a synonymous (silent) variant that is not predicted by SpliceAI to impact splicing. In addition, it occurs at a nucleotide that is not conserved. Therefore this variant has been classified as Likely Benign (BP4, BP7). |